Published in Vaccine Weekly, April 3rd, 1995
Researcher Pramod N. Nehete and colleagues previously reported the induction of major histocompatibility complex (MHC) class I-restricted, CD8 cytotoxic T lymphocytes (CTLs) specific to HIV-1 in mice by a 15-amino acid peptide (R15K) from the V3 loop in gp120.
In this study Nehete et al. present evidence suggesting that CTL activity induced by R15K was stable for eight to 10 weeks...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (1995-04-03)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.